These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8406186)
1. Sex steroid receptors in endometrial carcinoma. Satyaswaroop PG; Mortel R Gynecol Oncol; 1993 Sep; 50(3):278-80. PubMed ID: 8406186 [No Abstract] [Full Text] [Related]
2. Hormonal treatment of endometrial cancer: past, present and future. Podczaski E; Mortel R Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):469-89. PubMed ID: 11476566 [TBL] [Abstract][Full Text] [Related]
3. Steroid receptor concentrations as a prognostic factor in atypical endometrial hyperplasia. Lindahl B; Willén R Anticancer Res; 1998; 18(5B):3793-5. PubMed ID: 9854498 [TBL] [Abstract][Full Text] [Related]
4. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103 [TBL] [Abstract][Full Text] [Related]
5. [Endometrial adenocarcinoma: relationship between steroid receptors and the degree of cell differentiation]. Marroni P; Barbi GP; Zappa R; Nicolò G; Tanara G; Paganuzzi M; Ferrara GB Minerva Ginecol; 1987 May; 39(5):343-5. PubMed ID: 2819787 [No Abstract] [Full Text] [Related]
6. [Apparent heterogeneous distribution of progesterone receptors in certain cases of endometrial carcinoma]. Bernal A; Barahona E; Bernal MA Ginecol Obstet Mex; 1997 Mar; 65():96-100. PubMed ID: 9190359 [TBL] [Abstract][Full Text] [Related]
7. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women]. Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458 [TBL] [Abstract][Full Text] [Related]
8. Steroid receptor concentrations in endometrial carcinoma: effect on survival in surgically staged patients. Kadar N; Malfetano JH; Homesley HD Gynecol Oncol; 1993 Sep; 50(3):281-6. PubMed ID: 8406187 [TBL] [Abstract][Full Text] [Related]
9. [Progress of clinical uses of endocrine therapy in endometrial cancer]. Wang ZQ; Wang JL; Wei LH Zhonghua Yi Xue Za Zhi; 2005 May; 85(18):1293-6. PubMed ID: 16029624 [No Abstract] [Full Text] [Related]
10. [Hormonal receptors in cancer of the larynx]. Altissimi G; Simoncelli C; Angelini A Acta Otorhinolaryngol Ital; 1988; 8(4):423-35. PubMed ID: 3232526 [No Abstract] [Full Text] [Related]
11. Heterogeneity and progesterone-receptor distribution in endometrial adenocarcinoma. Mortel R; Zaino R; Satyaswaroop PG Cancer; 1984 Jan; 53(1):113-6. PubMed ID: 6689993 [TBL] [Abstract][Full Text] [Related]
12. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium. Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817 [TBL] [Abstract][Full Text] [Related]
13. [The factors affecting the level of ovarian hormone receptors in breast tumors in women]. Borisenkov MF; Bazhenov SM Ontogenez; 1999; 30(2):130-3. PubMed ID: 10368823 [TBL] [Abstract][Full Text] [Related]
14. Modulation of steroid receptors in rat mammary glands. Seshadri R; Shah PN Indian J Exp Biol; 1984 Oct; 22(10):523-6. PubMed ID: 6530249 [No Abstract] [Full Text] [Related]
15. [Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures]. Wang HY; Shen L; Sun Z Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):237-41. PubMed ID: 16759457 [TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical detection of estradiol and progesterone receptors in paraffin sections after treatment with microwaves. Comparison with biochemical assay of receptors in a series of 123 breast cancers with determination of the threshold of optimal positivity]. Vilain MO; Delobelle-Deroide A; Bloget F; Cabaret V; Peyrat JP; Fournier C; Hecquet B; Fournier J; Vennin P; Bonneterre J Ann Pathol; 1997 Apr; 17(2):82-8. PubMed ID: 9221007 [No Abstract] [Full Text] [Related]
17. Development of a preclinical model for hormonal therapy of human endometrial carcinomas. Satyaswaroop PG Ann Med; 1993 Apr; 25(2):105-11. PubMed ID: 8489746 [TBL] [Abstract][Full Text] [Related]
18. Hormone receptors in endometrial cancer. Gurpide E Cancer; 1981 Jul; 48(2 Suppl):638-41. PubMed ID: 7023668 [TBL] [Abstract][Full Text] [Related]
19. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383 [TBL] [Abstract][Full Text] [Related]
20. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]